Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Iterum Therapeutics PE Ratio 2017-2025 | ITRM

Current and historical p/e ratio for Iterum Therapeutics (ITRM) from 2017 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Iterum Therapeutics PE ratio as of July 02, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Iterum Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-03 0.96 0.00
2025-03-31 1.23 $-0.99 0.00
2024-12-31 1.77 $-1.31 0.00
2024-09-30 1.09 $-2.00 0.00
2024-06-30 1.15 $-2.00 0.00
2024-03-31 1.54 $-2.65 0.00
2023-12-31 1.97 $-2.97 0.00
2023-09-30 0.80 $-2.44 0.00
2023-06-30 1.07 $-4.52 0.00
2023-03-31 1.00 $-4.17 0.00
2022-12-31 0.84 $-3.69 0.00
2022-09-30 1.62 $-3.58 0.00
2022-06-30 3.00 $-0.90 0.00
2022-03-31 5.33 $0.30 17.76
2021-12-31 5.88 $-11.54 0.00
2021-09-30 8.38 $-15.44 0.00
2021-06-30 34.65 $-24.74 0.00
2021-03-31 21.15 $-37.33 0.00
2020-12-31 14.84 $-41.38 0.00
2020-09-30 15.75 $-61.02 0.00
2020-06-30 17.85 $-84.26 0.00
2020-03-31 40.65 $-101.20 0.00
2019-12-31 67.50 $-106.60 0.00
2019-09-30 86.55 $-108.55 0.00
2019-06-30 103.20 $-102.85 0.00
2019-03-31 118.83 $-107.20 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.039B $0.000B
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. It develops and markets therapies to address unmet medical needs, as well as provides anti-infectives to treat multi-drug resistant pathogens. The company's product pipeline consists of uncomplicated urinary tract infections, complicated urinary tract infections and complicated intra abdominal infections. Iterum Therapeutics plc is based in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $81.223B 30.47
Zoetis (ZTS) United States $70.824B 26.42
Takeda Pharmaceutical (TAK) Japan $49.065B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.191B 22.14
BeOne Medicines - (ONC) Cayman Islands $26.778B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.734B 0.00
Merck (MKKGY) Germany $17.176B 12.59
Summit Therapeutics (SMMT) United States $16.799B 0.00
Shionogi (SGIOY) Japan $15.040B 15.07
United Therapeutics (UTHR) United States $13.316B 11.78
Neurocrine Biosciences (NBIX) United States $12.806B 43.86
Orion OYJ (ORINY) Finland $10.495B 28.38
IPSEN (IPSEY) France $10.061B 0.00
Corcept Therapeutics (CORT) United States $7.565B 61.50
Stevanato Group S.p.A (STVN) Italy $7.414B 45.33
Ionis Pharmaceuticals (IONS) United States $6.938B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.664B 0.00
Grifols, S.A (GRFS) Spain $6.284B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.344B 0.00
Hypermarcas (HYPMY) Brazil $3.180B 20.92
Crinetics Pharmaceuticals (CRNX) United States $2.756B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.623B 14.19
Catalyst Pharmaceuticals (CPRX) United States $2.616B 9.17
NewAmsterdam Pharma (NAMS) Netherlands $2.129B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.887B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.835B 0.00
ARS Pharmaceuticals (SPRY) United States $1.645B 0.00
Endo (NDOI) United States $1.631B 0.00
Evotec AG (EVO) Germany $1.541B 0.00
Ocular Therapeutix (OCUL) United States $1.507B 0.00
Guardian Pharmacy Services (GRDN) United States $1.303B 0.00
Harrow (HROW) United States $1.121B 0.00
Dyne Therapeutics (DYN) United States $1.016B 0.00
Enliven Therapeutics (ELVN) United States $1.013B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.012B 20.24
Ardelyx (ARDX) United States $1.002B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Collegium Pharmaceutical (COLL) United States $0.980B 5.29
Akebia Therapeutics (AKBA) United States $0.953B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.852B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Xeris Biopharma Holdings (XERS) United States $0.740B 0.00
Elite Pharmaceuticals (ELTP) United States $0.641B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.604B 13.14
Xencor (XNCR) United States $0.591B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.586B 0.00
KalVista Pharmaceuticals (KALV) United States $0.586B 0.00
Bioventus (BVS) United States $0.563B 14.27
Theravance Biopharma (TBPH) United States $0.553B 0.00
Zevra Therapeutics (ZVRA) United States $0.515B 0.00
Organogenesis (ORGO) United States $0.514B 0.00
Siga Technologies (SIGA) United States $0.477B 9.97
Oruka Therapeutics (ORKA) United States $0.472B 0.00
Tourmaline Bio (TRML) United States $0.416B 0.00
Altimmune (ALT) United States $0.397B 0.00
AleAnna (ANNA) United States $0.391B 0.00
Aquestive Therapeutics (AQST) United States $0.366B 0.00
Savara (SVRA) United States $0.363B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 9.01
Heron Therapeutics (HRTX) United States $0.328B 0.00
Nektar Therapeutics (NKTR) United States $0.317B 0.00
Nature's Sunshine Products (NATR) United States $0.280B 25.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.259B 0.00
Aldeyra Therapeutics (ALDX) United States $0.240B 0.00
Liminatus Pharma (LIMN) United States $0.229B 0.00
Esperion Therapeutics (ESPR) United States $0.228B 0.00
OmniAb (OABI) United States $0.227B 0.00
Nanobiotix S.A (NBTX) France $0.223B 0.00
MediWound (MDWD) Israel $0.207B 0.00
China SXT Pharmaceuticals (SXTC) China $0.207B 0.00
4D Molecular Therapeutics (FDMT) United States $0.200B 0.00
Larimar Therapeutics (LRMR) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.183B 0.00
Journey Medical (DERM) United States $0.164B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Lexeo Therapeutics (LXEO) United States $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.140B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
Korro Bio (KRRO) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.120B 0.00
Nutriband (NTRB) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.115B 0.00
Champions Oncology (CSBR) United States $0.107B 17.66
Protara Therapeutics (TARA) United States $0.107B 0.00
VAXART, INC (VXRT) United States $0.100B 0.00
Cassava Sciences (SAVA) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.095B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Fractyl Health (GUTS) United States $0.080B 0.00
Achieve Life Sciences (ACHV) Canada $0.078B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.074B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Metagenomi (MGX) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.060B 0.00
Unicycive Therapeutics (UNCY) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Context Therapeutics (CNTX) United States $0.057B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.89
Gain Therapeutics (GANX) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
Mural Oncology (MURA) Ireland $0.043B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Jupiter Neurosciences (JUNS) United States $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.039B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.023B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
FibroGen (FGEN) United States $0.021B 0.00
DURECT (DRRX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.018B 0.00
BioVie (BIVI) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
Plus Therapeutics (PSTV) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Ainos (AIMD) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.11
Cosmos Health (COSM) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
SHINECO (SISI) China $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
ProKidney (PROK) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00